Top Markets
Coin of the day
Sunwin Stevia International, Inc. Sunwin Stevia International, Inc.

Sunwin Stevia International, Inc.

SUWN
株式のランク #41454
Sunwin Stevia International, Inc. (SUWN) is a China-based company specializing... Sunwin Stevia International, Inc. (SUWN) is a China-based company specializing in the manufacture and distribution of natural sweetening agents and various pharmaceutical products, primarily serving the People's Republic of China. The company's operations are structured into two principal divisions: Stevioside, and Corporate and Other Pharmaceutical. Under its stevioside segment, Sunwin produces a diverse range of steviol glycoside compounds, with rebaudioside A and stevioside as their key active components. Its product offerings include Steviosin, a low-calorie stevia extract designed for medicinal use, and OnlySweet, a zero-calorie tabletop sweetener. These products are supplied to a broad clientele, encompassing food and drug manufacturers, ingredient distributors, and international trade companies. Additionally, the firm is involved in the production and sale of Metformin, a widely utilized medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. maintains its headquarters in Qufu, China.
株価
$0.0001
最終同期: 2025-04-22
時価総額
$19.96K
変化(1日)
0.00%
変化(1年)
0.00%
CN
取引 Sunwin Stevia International, Inc. (SUWN)

カテゴリー

Sunwin Stevia International, Inc.(SUWN)の収益
Aug 2026 時点の収益 TTM: 0
Sunwin Stevia International, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Sunwin Stevia International, Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益